Mustafa Sahin, MD, PhD, Neurologist-in-Chief and Chair of nan Department of Neurology astatine Boston Children's Hospital, and his collaborators person been awarded an NIH assistance of complete $8.6 cardinal for nan 3rd five-year rhythm of nan Rare Disease Clinical Research Network (RDCRN) project, "Developmental Synaptopathies Associated pinch TSC, PTEN, SHANK3, and SynGAP1 Pathogenic Variants".
This grant, which now involves 13 hospitals crossed nan United States, intends to proceed nan broad characterization of individuals pinch these uncommon diseases, focusing connected cognition, communication, and neuropsychiatric symptoms. The task besides seeks to create neurophysiological biomarkers of slumber and sensory deficits, support aviator projects done strategical disorder-specific priorities, and foster a caller procreation of skilled investigators. Additionally, efforts to grow nan investigation activities and effective dissemination of information, and scheme for nan consortium's sustainability beyond RDCRN backing will besides beryllium a main attraction of nan adjacent 5 years. This inaugural represents a important measurement guardant successful some uncommon illness investigation and diligent advocacy.
Our activity pinch galore institutions crossed nan United States and business pinch galore diligent defense groups to day person brought respective objective involution tests to these uncommon familial neurodevelopmental disorders. Our infrastructure and acquisition besides supply a roadmap for comparative study crossed conditions pinch nan extremity of providing much therapeutic opportunities for these uncommon illness communities."
Dr. Sahin, Consortium Lead Principal Investigator
English (US) ·
Indonesian (ID) ·